🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Subjects with perennial allergic rhinitis will be randomized to 320 mcg of ...
Status
Completed
Location
Teva Clinical Sudy Site
Start Date
2009-10-31
Trial ID
NCT00988247
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of the fixe...
Status
Completed
Location
Research Center
Start Date
2006-06
Trial ID
NCT00393952
The primary purpose of this study is to demonstrate the equivalence of bude...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-10-17
Trial ID
NCT06340581
This is a Phase 3, randomized, placebo-controlled, double-blind,double-dumm...
Status
Completed
Location
Teva Investigational Site 10851
Start Date
2013-12
Trial ID
NCT02031640
Treatments Being Tested
This study is examining how well a dry powder inhaler (DPI) of albuterol me...
Status
Completed
Location
Teva Clinical Study Site
Start Date
2010-02
Trial ID
NCT01058863
Treatments Being Tested
This is a 16 week multicentre, multinational, randomised, double-blind, dou...
Status
Completed
Location
205.342.43002 Boehringer Ingelheim Investigational Site
Start Date
2006-07
Trial ID
NCT00350207
Treatments Being Tested
The objectives of this study are to measure Impulse Oscillometry (IOS) in p...
Status
Unknown
Location
Allergy and Asthma Center of El Paso
Start Date
2008-09
Trial ID
NCT00867737
Treatments Being Tested
The purpose of the study is to assess the propellants,1 - Difluoroethane \[...
Status
Completed
Location
GSK Investigational Site
Start Date
2025-03-11
Trial ID
NCT06702462
Treatments Being Tested
Assess regional changes to perfusion and ventilation from inhaled corticost...
Status
Recruiting
Location
University of Miami - Converge Miami
Start Date
2026-04-27
Trial ID
NCT07426458
Treatments Being Tested
The aim of this trial is to evaluate the efficacy and safety of 2.5 and 5 m...
Status
Completed
Location
205.419.01058 Boehringer Ingelheim Investigational Site
Start Date
2010-08
Trial ID
NCT01172821